75 / 84
75
30. Chen J, Liu C. Is sulfasalazine effective in
ankylosing spondylitis? A systematic review of
randomized controlled trials. J Rheumatol
2006;33:722-31.
31. Song IH, Althoff CE, Haibel H, Hermann KG,
Poddubnyy D, Listing J, et al. Frequency and
duration of drug-free remission after 1 year of
treatment with etanercept versus sulfasalazine in
early axial spondyloarthritis: 2 year data of the
ESTHER trial. Ann Rheum Dis 2012; 71:1212-5.
32. van Denderen JC, van der Paardt M,
Nurmohamed MT, de Ryck YM, Dijkmans BA, van
der Horst-Bruinsma IE. Double blind, randomised,
placebo controlled study of leflunomide in the
treatment of active ankylosing spondylitis. Ann
Rheum Dis 2005;64:1761-4.
33. Braun J, Brandt J, Listing J, Zink A, Alten R,
Golder W, et al. Treatment of active ankylosing
spondylitis with infliximab: a randomized
controlled multicentre trial. Lancet 2002;359:1187-93.
34. Braun J, Brandt J, Listing J, Zink A, Alten R,
Burmester G, et al. Long-term efficacy and safety of
infliximab in the treatment of ankylosing
spondylitis: an open, observational, extension study
of a three-month, randomized, placebo-controlled
trial. Arthritis Rheum 2003;48:2224-33.
35. Listing J, Brandt J, Rudwaleit M, Zink A, Sieper
J, Braun J. Impact of anti-tumour necrosis factor